Carol D. Miller bought Quest Diagnostics Incorporated (NYSE: DGX)
Carol D. Miller bought DGX · disclosed September 2, 2022
Carol D. Miller, a WV House member representing District 1, purchased $15,001 - $50,000 of Quest Diagnostics Incorporated (DGX) on July 28, 2021. Filings associated with Carol D. Miller disclosed 0 other DGX transactions in the 12 months before this trade. Shares of DGX have risen 86.0% since the first observed purchase on July 28, 2021. The filing was publicly disclosed on September 2, 2022; a direct filing link is not available in the current data record.
Follow this and other congressional disclosures on the Quantellect congress trading dashboard. For Carol D. Miller's complete filing history, visit Carol D. Miller's full trade history. Browse all trading members of Congress tracked by Quantellect.
Key points
- Analyst ratings on DGX break down as 0 strong buy, 4 buy, 7 hold, 0 sell, 0 strong sell.
- DGX carries a Risk Score of 96 as of September 4, 2026. On this scale, a higher score means a lower risk surface.
- Carol D. Miller bought DGX in the amount range of $15,001 - $50,000 on July 28, 2021, filed under the STOCK Act.
- The filing lists Spouse as the transaction owner and was disclosed n/a after the trade.
- The asset description in the filing reads 'Quest Diagnostics Incorporated (DGX) [ST].'
- Filings associated with Carol D. Miller disclosed 0 other DGX transactions in the 12 months before this trade.
- Shares of DGX have risen 86.0% since the first observed purchase on July 28, 2021.
- DGX carried a Q Score of 96 in its equity peer group as of September 4, 2026.
- DGX carried a Squeeze Score of 25 as of September 8, 2026.
Did Carol D. Miller buy or sell DGX?
The Periodic Transaction Report covers a single purchase involving DGX on July 28, 2021. The filed amount range is $15,001 - $50,000. The asset description reads 'Quest Diagnostics Incorporated (DGX) [ST]', as submitted by the filer. The report was submitted on September 2, 2022. Under the STOCK Act, covered transactions generally must be reported within 30 days of receiving notice and no later than 45 days after the transaction.
| Politician | Action | Ticker | Amount | Trade date | Filed |
|---|---|---|---|---|---|
| Carol D. Miller (House) | Buy | DGX | $15,001 - $50,000 | July 28, 2021 | September 2, 2022 |
What other DGX trades has Carol D. Miller disclosed in the past 12 months?
Filings associated with Carol D. Miller disclosed 0 other DGX transactions in the 12 months before this trade.
| Trade date | Action | Owner | Amount | Filing |
|---|---|---|---|---|
| No other DGX transactions were disclosed in the prior 12 months. | ||||
What does the filing show, and what does it not show?
The filing reports a purchase involving DGX by Carol D. Miller in the amount range of $15,001 - $50,000, with Spouse listed as the owner. It does not establish Carol D. Miller's total holdings in DGX, any realized profit or loss, the reasons for the transaction, or any committee connection. The asset description reads 'Quest Diagnostics Incorporated (DGX) [ST]', as submitted by the filer; that label is reproduced without adding a legal or regulatory interpretation. Quantellect's current profile data does not identify Carol D. Miller's committee assignments, so this article draws no connection between the trade and any legislative jurisdiction. Filings associated with Carol D. Miller disclosed 0 other DGX transactions in the 12 months before this trade. Quantellect tracks how disclosed purchases have performed, but does not treat corporate actions as buys or sells.
Who else in Congress traded DGX?
Quantellect's current database lists these recent DGX disclosures by other members. Owner labels come from the native filing row; an official filing link appears only when it is available in the source data.
| Member | Party | Action | Amount | Disclosed |
|---|---|---|---|---|
| Alan Armstrong Self | R Senate | Buy | $1,001 - $15,000 | July 21, 2026Filing unavailable |
| Alan Armstrong Self | R Senate | Buy | $1,001 - $15,000 | July 21, 2026Filing unavailable |
| Rohit Khanna Spouse | D House | Sell | $1,001 - $15,000 | March 9, 2026Filing unavailable |
| Rohit Khanna Spouse | D House | Buy | $1,001 - $15,000 | February 6, 2026Filing unavailable |
| Julie Johnson Joint | D House | Sell | $1,001 - $15,000 | December 11, 2025Filing unavailable |
How has Carol D. Miller's disclosed trading performed?
Carol D. Miller holds a Quantellect Q Score of 14 (weak), a descriptive rating of disclosed congressional buys over the trailing 24 months, based on estimated, unrealized results from filed amount ranges and closing prices.
Q Score rank #67 of 77 rated members. The rating covers buys only: entry uses the transaction-date close, positions are marked to the latest close, and dollar figures are estimates from the disclosed ranges, not realized gains. It describes disclosed activity and is not investment advice.
All Carol D. Miller DGX trades
Estimated profit is shown for buys only, marked to the latest close. It is an estimate and does not net later sells, taxes, or fees.
Frequently asked questions
Did Carol D. Miller buy or sell DGX?
According to the disclosure, Carol D. Miller purchased DGX on July 28, 2021.
What amount was reported for the DGX transaction?
The disclosure reports $15,001 - $50,000 for the purchase. Filed amounts are ranges, not exact transaction values.
When did the transaction occur, and when was it disclosed?
The transaction is dated July 28, 2021, and it was disclosed on September 2, 2022.
Where can I see Carol D. Miller's other congressional trades?
Quantellect lists Carol D. Miller's complete disclosed trade history on the member profile. Carol D. Miller's trade history
Is congressional stock trading legal?
The STOCK Act does not impose a blanket ban on members holding or trading individual securities. It requires public disclosure of covered transactions, generally within 30 days of receiving notice and no later than 45 days after the transaction. Other laws and chamber rules may also apply. STOCK Act
Is Congress exempt from insider trading laws?
No. The STOCK Act expressly affirms that members and congressional employees are not exempt from federal insider-trading prohibitions and owe a duty arising from their positions. Public disclosure is a separate obligation and does not shield a trade from those laws. STOCK Act
How quickly must members of Congress disclose a trade?
Under the STOCK Act, a covered transaction generally must be reported on a Periodic Transaction Report within 30 days of receiving notice and no later than 45 days after the transaction. House Ethics guidance describes the reporting schedule and applicable late-filing fee. House Ethics PTR guidance
How is net worth reported in these disclosures?
It is not. STOCK Act filings report transaction and asset ranges, not a complete or real-time net worth. Quantellect does not estimate a member's net worth from these filings; any third-party estimate is not part of the official disclosure. STOCK Act
Browse all members of Congress who trade stocks·See which stocks Congress trades·Congressional trading overview
Trades reflect disclosures filed under the STOCK Act and are provided for informational purposes only, not investment advice. Amounts are ranges from official filings; estimated prices and post-trade returns are derived from end-of-day market data and may be revised as filings are amended.